Lack of effect on ambulation of dalfampridine-ER (4-AP) treatment in adult SMA patients.
Neuromuscul Disord. 2020 Aug;30(8):693-700. doi: 10.1016/j.nmd.2020.07.007. Epub 2020 Jul 18.
Neuromuscul Disord. 2020.
PMID: 32788051
Clinical Trial.